We are constantly working to improve the site, and to add more laws to our database. If you are receiving value from using our site please consider signing up for a subscription to support the site and to get many additional benefits for you.
Key Benefits:
(You can close this ad by clicking anywhere on the page.)
Key Benefits:
Date 30 December 2011 was published in the "Official Gazette of the State", number 314, the Resolution of 28 December 2011, of the Directorate General of Pharmacy and Health Products, determining the new Hospital sets of medicinal products and their reference prices, proceeding with the creation of the set H66 (Parenteral Vinorelbina) and its reference prices for the medicinal products in the integrated one.
The drug that has been used as a basis for the calculation of the reference price of set H66 (Parenteral Vinorelbina) has been excluded from the pharmaceutical provision of the National Health System, prior to the effectiveness of the the resolution cited. Once the error was noticed in the Resolution of 28 December 2011, of the Directorate General of Pharmacy and Health Products, published in the "Official Gazette of the State", number 314, of 30 December 2011, determining the new (a) a set of medicinal products which are at the hospital level and their reference prices and in order to ensure the proper supply of the market and the particular seriousness of the pathologies to which these medicinal products are intended, according to the indications authorised on the technical fiche and without any alteration of the material content of the information, make the appropriate corrections:
On page 146138,
Where he says:
|
Set | Active Principle | Administration Path |
National Code | Presentation Name | PVL Reference | |
|---|---|---|---|---|---|---|
|
H66 | Vinorelbin. | 658375 | 658375 | VINORELBINE FERRER FARMA 10 mg/ml concentrate for solution for infusion, 1 ml. |
H66 |
H66 | PARENTERAL. | PARENTERAL. |
| Centro_table_body "> 658376 | VINORELBINE FERRER FARMA 10 mg/ml concentrate for solution for infusion, 5 ml. | 13.67 | ||||
| H66 | Vinorelbine. | PARENTERAL. | 661834 | VINORELBINE ACTAVIS 10 mg/ml concentrate for solution for infusion, 1 vial of 1 ml. | 2.73 | |
| H66 | Vinorelbin. | PARENTERAL. | 661836 | VINORELBINE ACTAVIS 10 mg/ml concentrate for solution for infusion, 10 vials of 1 ml. | 27.33 | |
|
H66 |
Vinorelbin. | PARENTERAL. |
661837 | VINORELBINE ACTAVIS 10 mg/ml concentrate for solution for infusion, 1 vial of 5 ml. | 13.67 |
|
| H66 | Vinorelbin. | PARENTERAL. | 661838 |
VINORELBINE ACTAVIS 10 mg/ml concentrate for solution for infusion, 10 5 mL vials | 136.67 | |
|
H66 | Vinorelbine. | 663101 | VINORELBINE TEVA 10 mg/ml concentrate for solution for infusion, 1 vial of 1 ml. | 2.73 | ||
| H66 | H66 |
663102 |
VINORELBINE TEVA 10 mg/ml concentrate for solution for infusion, 1 vial of 5 ml. | 13.67 | ||
| H66 | Vinorelbine. | 665673 | 665673 |
VINIRELBINA IPS 10 mg/ml concentration for solution for infusion, 1vial of 1 ml. | 2.73 | |
|
H66 |
Vinorelbin. | PARENTERAL. | 665674 | VINIRELBINA IPS 10 mg/ml concentration for solution for infusion, 1 vial of 5 ml. | 13.67 | |
|
H66 | Vinorelbin. | PARENTERAL. | 669374 | NAVELBINE 10MG/VIAL 1 VIAL 1ML SOLC INY. | 2.73 | |
| H66 |
PARENTERAL. | PARENTER_TABLE_TABLE_TABLE_IZQ"> Centro_table_body"> 669382 | NAVELBINE 50MG/VIAL 1 VIAL 5ML SOLC INY. | 13.67 |
You must say:
|
Set | Active Principle | Administration Path |
National Code | Presentation Name | PVL Reference | |
|---|---|---|---|---|---|---|
|
H66 | Vinorelbin. | 658375 | 658375 | VINORELBINE FERRER FARMA 10 mg/ml concentrate for solution for infusion, 1 ml. | 6.30 | |
| H66 | PARENTERAL | PARENTERAL. | Centro_table_body "> 658376 | VINORELBINE FERRER FARMA 10 mg/ml concentrate for solution for infusion, 5 ml. | 31.50 | |
| H66 | Vinorelbine. | PARENTERAL. | 661834 | VINORELBINE ACTAVIS 10 mg/ml concentrate for solution for infusion, 1 vial of 1 ml. | 6.30 | |
| H66 | Vinorelbin. | PARENTERAL. | 661837 | VINORELBINE ACTAVIS 10 mg/ml concentrate for solution for infusion, 1 vial of 5 ml. | 31.50 | |
|
H66 |
Vinorelbin. | PARENTERAL. |
663101 | VINORELBINE TEVA 10 mg/ml concentrate for solution for infusion, 1 vial of 1 ml. | 6.30 | |
| H66 | Vinorelbin. | PARENTERAL. | 663102 | VINORELBINE TEVA 10 mg/ml concentrate for solution for infusion, 1 vial of 5 ml. | 31.50 | |
| H66 | Vinorelbin. | PARENTERAL. | 665673 | VINORELBINA IPS 10 mg/ml concentration for solution for infusion, 1vial of 1 ml. | 6.30 |
|
|
H66 |
PARENTERAL. |
665674 | VINORELBINA IPS 10 mg/ml concentration for solution for infusion, 1 vial of 5 ml. | 31.50 | ||
| H66 | Vinorelbine. | 669374 | 669374 | NAVELBINE 10MG/VIAL 1 VIAL 1ML SOLC INY. | 6.30 | |
| H66 | PARENTERAL. | 669382 | NAVELBINE 50MG/VIAL 1 VIAL 5ML SOLC INY. | 31.50 |
On page 146140,
Where he says:
|
Code | Active Principle | Administration Path |
DDD | Drive | National Code | Presentation Name | CTD | |
|---|---|---|---|---|---|---|---|---|
| H66 |
PARENTERAL. | 50,000000 | mg. | 661838 | VINORELBINE ACTAVIS 10 mg/ml concentrate for solution for infusion, 10 vials of 5 ml. | 13,667000 |
You must say:
|
Code | Active Principle | Administration Path |
DDD | Drive | National Code | Presentation Name | CTD | |
|---|---|---|---|---|---|---|---|---|
| H66 |
PARENTERAL. | 50,000000 | mg. | 661837 | VINORELBINE ACTAVIS 10 mg/ml concentrate for solution for infusion, 1 vial of 5 ml. | 31,500000 |
Madrid, April 17, 2012. -Director General of the Basic Portfolio of Services of the National System of Health and Pharmacy, Maria del Sagrario Pérez Castellanos.
